Stephen K. Brannan, MD, and John D. Young Appointed to Slate Medicines Board of Directors

By Karen Roman Slate Medicines, Inc. said Stephen K. Brannan, MD, and John D. Young were appointed to the company’s Board of Directors. Dr. Brannan has over 25 years of clinical development experience in central nervous system disorders and previously served as Chief Medical Officer of Karuna Therapeutics, the company said. He also held clinical […] The post Stephen K. Brannan, MD, and John D. Young Appointed to Slate Medicines Board of Directors appeared first on ExecEdge.